453
Views
1
CrossRef citations to date
0
Altmetric
Articles

Effect of education and telephone counseling on adherence to treatment and challenges experienced in anti-TNF-α treatment: a pilot study

, , , &
Pages 108-119 | Received 22 Mar 2017, Accepted 21 Dec 2017, Published online: 18 Jan 2018

References

  • Alparslan, G. B., & Kapucu, S. S. (2010). The changes and difficulties experienced by patients using steroids. Journal of Renal Care, 36(2), 81–89. doi: 10.1111/j.1755-6686.2010.00143.x
  • American College of Rheumatology (ACR). (2014). Anti TNF drugs. Retrieved from https://www.rheumatology.org/Practice/Clinical/Patients/Medications/Anti-TNF/
  • Baert, F., Noman, M., Vermeire, S., Van Assche, G., D’Haens, G., Carbonez, A., & Rutgeerts, P. (2003). Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s disease. The New England Journal of Medicine, 348(7), 601–608. doi: 10.1056/NEJMoa020888
  • van den Bemt, B. J., Zwikker, H. E., & van den Ende, C. H. (2012). Medication adherence in patients with rheumatoid arthritis: A critical appraisal of the existing literature. Expert Review of Clinical Immunology, 8(4), 337–351. doi: 10.1586/eci.12.23
  • van den Bemt, B. J., van den Hoogen, F. H., Benraad, B., Hekster, Y. A., van Riel, P. L., & van Lankveld, W. (2009). Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. The Journal of Rheumatology, 36(10), 2164–2170. doi: 10.3899/jrheum.081204
  • Biese, K., LaMantia, M., Shofer, F., McCall, B., Roberts, E., Stearns, S. C., … Busby-Whitehead, J. (2014). A randomized trial exploring the effect of a telephone call follow-up on care plan compliance among older adults discharged home from the emergency department. Academic Emergency Medicine, 21(2), 188–195. doi: 10.1111/acem.12308
  • Birol, L. (2004). Hemşirelik süreci: Hemşirelik bakımında sistematik yaklaşım (5th ed., pp. 133–156, 180–192). İzmir: Etki Matbaacılık Yayıncılık Ltd. Şti.
  • Borah, B. J., Huang, X., Zarotsky, V., & Globe, D. (2009). Trends in RA patients’ adherence to subcutaneous anti-TNF therapies and costs. Current Medical Research and Opinion, 25(6), 1365–1377. doi: 10.1185/03007990902896386
  • Carpenito-Moyet, L. J. (2012). Hemşirelik tanıları. In F. Erdemir (Ed.), Hemşirelik tanıları el kitabı (pp. 45–529). İstanbul: Nobel Kitabevi.
  • Chrzanowska, A., Batko, B., Hajdyła-Banaś, I., Banaś, T., Krezelok, M., & Ludwin, A. (2013). Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Przeglad Lekarski, 71(4), 199–203.
  • Colombel, J.-F., Loftus, E. V., Tremaine, W. J., Egan, L. J., Harmsen, W. S., Schleck, C. D., … Sandborn, W. J. (2004). The safety profile of infliximab in patients with Crohn’s disease: The Mayo Clinic experience in 500 patients. Gastroenterology, 126(1), 19–31. doi: 10.1053/j.gastro.2003.10.047
  • Curkendall, S., Patel, V., Gleeson, M., Campbell, R. S., Zagari, M., & Dubois, R. (2008). Compliance with biologic therapies for rheumatoid arthritis: Do patient out-of-pocket payments matter? Arthritis Care Research (Hoboken), 59(10), 1519–1526. doi: 10.1002/art.24114
  • Esposito, M., Gisondi, P., Cassano, N., Babino, G., Cannizzaro, M. V., Ferrucci, G., … Giunta, A. (2014). Treatment adherence to different etanercept regimens, continuous vs. intermittent, in patients affected by plaque-type psoriasis. Drug Development Research, 75(Suppl. 1), S31–S34. doi: 10.1002/ddr.21190
  • Fall, E., Chakroun, N., Dalle, N., & Izaute, M. (2013). Is patient education helpful in providing care for patients with rheumatoid arthritis? A qualitative study involving French Nurses. Nursing & Health Science, 15, 346–352. doi: 10.1111/nhs.12042
  • Fidder, H., Schnitzler, F., Ferrante, M., Noman, M., Katsanos, K., Segaert, S., … Rutgeerts, P. (2009). Long-term safety of infliximab for the treatment of inflammatory bowel disease: A single-centre cohort study. Gut, 58(4), 501–508. doi: 10.1136/gut.2008.163642
  • Fidder, H. H., Singendonk, M. M. J., Have, M., Oldenburg, B., & Oijen, M. G. H. (2013). Low rates of adherence for tumor necrosis factor-α inhibitors in Crohn’s disease and rheumatoid arthritis: Results of a systematic review. World Journal of Gastroenterology, 19(27), 4344–4350. doi: 10.3748/wjg.v19.i27.4344
  • Glintborg, B., Østergaard, M., Dreyer, L., Krogh, N. S., Tarp, U., Hansen, M. S., … Hetland, M. L. (2011). Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry. Arthritis & Rheumatology, 63(2), 382–390. doi: 10.1002/art.30117
  • Gniadecki, R., Bang, B., Bryld, L. E., Iversen, L., Lasthein, S., & Skov, L. (2015). Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris. British Journal of Dermatology, 172(1), 244–252. doi: 10.1111/bjd.13343
  • Hill, J. (2005). Adherence with drug therapy in the rheumatic diseases part one: A review of adherence rates. Musculoskeletal Care, 3(2), 61–73. doi: 10.1002/msc.27
  • Hintistan, S., & Çilingir, D. (2012). Hemşirelik uygulamalarında güncel bir yaklaşım: Telefon kullanımı. Hemşirelikte Eğitim ve Araştırma Dergisi, 9(1), 30–35.
  • Jacobi, C. E, Boshuizen, H. C., Rupp, I., Dinant, H. J. & Van Den Bos, G. A. M. (2004). Quality of rheumatoid arthritis care: The patient’s perspective. International Journal for Quality in Health Care, 16(1), 73–81. doi: 10.1093/intqhc/mzh009
  • Kaya, N. (2012) Romatoid artirit ve bakım. In Z. Durna (Ed.), Kronik hastalıklar ve bakım (pp. 441–478). İstanbul: Nobel Tıp Kitabevi.
  • Kroenke, K., Krebs, E. E., Wu, J., Yu, Z., Chumbler, N. R. & Bair, M. J. (2014). Telecare collaborative management of chronic pain in primary care: A randomized clinical trial. JAMA, 312(3), 240–243. doi: 10.1001/jama.2014.7689
  • Lopez, A., Billioud, V., Peyrin-Biroulet, C., & Peyrin-Biroulet, L. (2013). Adherence to anti-TNF therapy in inflammatory bowel diseases: A systematic review. Inflammatory Bowel Disease, 19(7), 1528–1533. doi: 10.1097/MIB.0b013e31828132cb
  • Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67–74. doi: 10.1097/00005650-198601000-00007
  • Nesari, M., Zakerimoghadam, M., Rajab, A., Bassampour, S., & Faghihzadeh, S. (2010). Effect of telephone follow-up on adherence to a diabetes therapeutic regimen. Japan Journal of Nursing Science, 7(2), 121–128. doi: 10.1111/j.1742-7924.2010.00146.x
  • Palmer, D., & El Miedany, Y. (2011). Rheumatology helpline: Challenges in the biologic therapy era. British Journal of Nursing, 20(12), 728–732. doi: 10.12968/bjon.2011.20.12.728
  • Pay, S. (2006). Romatizmal hastalıklarda anti-TNF ilaç kullanımı. Turkey Clinics Journal of Medical Sciences, 26(4), 130–430.
  • Ramelet, A.-S., Fonjallaz, B., Rapin, J., Gueniat C., & Hofer, M. (2014). Impact of a telenursing service on satisfaction and health outcomes of children with inflammatory rheumatic diseases and their families: A crossover randomized trial study protocol. BMC Pediatrics, 14(1), 151. doi: 10.1186/1471-2431-14-151
  • Sezgin, D., & Mert, H. (2010). Hastalık modifiye edici antiromatizmal ilaç tedavisi alan bireylerin tedavi algılarının uyuma etkisi. Dokuz Eylül Üniversitesi Hemşirelik Yüksekokulu Elektronik Dergisi, 3(1), 2–8.
  • Thwaites, C., Ryan, S., & Hassell, A. (2008). A survey of rheumatology nurse specialists providing telephone helpline advice within England and Wales. Rheumatology, 47(4), 522–525. doi: 10.1093/rheumatology/ken041
  • World Health Organization (WHO). (2003). Noncommunicable diseases and mental health adherence to long-term therapies project. Adherence to long-term therapies. Evidence for Action. 2003, Section II; 21–33. Retrieved from http://www.who.int/chp/knowledge/publications/adherence_introduction.pdf?ua=1
  • World Health Organization (WHO). (2015). Chronic diseases and health promotion. Chronic rheumatic conditions. Retrieved from http://www.who.int/chp/topics/rheumatic/en/
  • Yılmaz, S. (2004). Psikiyatri hastalarında ilaç yan etkileri ve ilaç uyumu. İstanbul: Hemşirelik Programı Yayınlanmamış Yükseklisans Tezi, İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.